Developing innovative therapies for the treatment of neurodegenerative conditions and advanced liver disease.
BioVie Inc. is a biotechnology company dedicated to developing innovative therapies for neurodegenerative conditions and advanced liver disease. With a focus on finding solutions for healthier brains, improved memory, and enhanced movement, BioVie Inc. is at the forefront of medical research. The company's neurology strategy centers around the nexus of biochemistry, cellular energetics, and neuroprotection, enabling exploration of pipeline molecules to decrease inflammation, enhance glucose utilization, protect neurons, and facilitate energy transfer within the central nervous system. BioVie Inc. aims to improve memory, movement, and overall brain health. The company's lead neuroscience molecule (NE3107) is currently being investigated in human clinical studies to assess its hypothesized impact on both Alzheimer’s and Parkinson’s diseases, exploring the possibilities of improved outcomes and reduced medical burdens.
In its cirrhosis studies, BioVie Inc. is working to determine if its exploratory technology can help individuals diagnosed with cirrhosis-related ascites (fluid that builds up inside the abdomen) to be more comfortable, require fewer or less frequent medical procedures to drain ascites fluid, and to help people with ascites live outside of the hospital for longer periods. BioVie is currently investigating BIV-201, a novel formulation of terlipressin, in human clinical trials. In BioVie’s studies of BIV-201, the exploratory medication is provided as a continuous infusion formulation delivered by a small, portable pump that the user can wear while engaging in typical tasks and activities at home.
Headquartered at 680 W Nye Ln, Carson City, Nevada 89703, US, BioVie Inc. is committed to advancing scientific research and clinical research to improve patient outcomes. BioVie Inc. invites you to explore the possibilities of improved health and well-being through its innovative therapies. Management is actively working to enhance and complete the company's profile, with more detailed information coming soon. To the manager of BioVie Inc., we invite you to create a customized and exclusive company showcase and product listing on our platform.
Compare BioVie Inc. with 3 companies in Biotechnology
| Comparison Field |
BioVie Inc.Main Company |
German Center for Ne...View Profile |
Ananda DevicesView Profile |
QynapseView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2009 | 2015 | 2015 |
|
Company Size
|
— | 1,001-5,000 | 11-50 | 11-50 |
|
City
|
Carson City, Nevada | Bonn, NRW | Laval, QC | |
|
Country
|
Germany | Canada | ||
|
Skills & Keywords
Comparing with main company
|
19 Total Skills
Biotechnology
Neurodegenerative Diseases
Liver Disease
Alzheimer's
Parkinson's
Clinical Trials
Pharmaceuticals
Liver Cirrhosis
Neurodegenerative
Cirrhosis
BioTech
Cognitive Decline
Dementia
Liver
Neuroscience
NE3107
Ascites
Scientific Research
Clinical Research
|
10 Total
10 Unique
Unique Skills:
Alzheimer
Amyotrophic lateral sclerosis
Ataxia
Demenz
Hirnforschung
Huntington's
+4
|
23 Total
23 Unique
Unique Skills:
ALS
Anti-Toxin
Biomarker Identification
Cell Culture
Chemotherapeutics
CNS
+17
|
16 Total
16 Unique
Unique Skills:
Artificial Intelligence
Azheimer's
Central Nervous System
Diagnosis
Disease Trajectory
Drug Efficacy
+10
|
Other organizations in the same industry
This company is also known as